Influenza viruses are important pathogens that affect multiple animal species, including
humans. There are four types of influenza viruses: A, B, C, and D (IAV, IBV, ICV, and IDV …

Individuals aged 65 years and above are at increased risk of complications and death from
influenza compared with any other age group. Enhanced vaccines, as the MF59® …

Background Seasonal influenza vaccines protect against three (trivalent influenza vaccine,
IIV3) or four (quadrivalent influenza vaccine, IIV4) viruses. IIV4 costs more than IIV3, and …

Studying influenza A virus (IAV) requires the use of secondary approaches to detect the
presence of virus in infected cells. To overcome this problem, we and others have generated …

Abstract Background The Advisory Committee on Immunization Practices (ACIP) uses the
Evidence to Recommendations Framework that includes cost-effectiveness analyses (CEA) …

This study investigated the impact of a longitudinal quality improvement continuing medical
education (CME) intervention on influenza and pneumococcal vaccination rates for patient …

Objectives Despite its importance of quality measures used by the Centers for Medicare and
Medicaid Services, the underlying cost-effectiveness evidence has not been examined. This …

Objective Patients with chronic conditions have higher rates of severe influenza-related
illness and mortality. However, influenza vaccination coverage in high-risk populations …

Secondary experimental procedures such as immunostaining have been utilized to study
wild-type influenza A viruses (IAV) but are inadequate to rapidly determine the virus in …

Objective This study evaluates the cost-effectiveness of extending the Dutch influenza
vaccination program for elderly and medical high-risk groups to include pediatric influenza …